Results 21 to 30 of about 18,120 (266)
Botulinum Toxin Type A for Treatment of Masseter Hypertrophy: Volumetric Analysis of Masseter Muscle Reduction over Time [PDF]
Archives of Aesthetic Plastic Surgery, 2016 Background There has been increasing interest in facial contouring procedures throughout Asian countries. As such, botulinum toxin A injections for masseteric hypertrophy have become a common procedure provided to patients who desire non-surgical ...
Edward Ilho Lee +4 more
doaj +1 more source
ABCS Health Sciences, 2022 Introduction: The use of botulinum toxin type A (BTX-A) to correct gummy smile has become popular in recent years. Objective: To evaluate the effects of BTX-A application in the correction of gummy smile 2 and 32 weeks after application.
Carlos Eduardo Alonso Vieira +7 more
doaj +1 more source
Toxins, 2021 Botulinum toxin type A (BoNT-A) represents a first-line treatment for spasticity, a common disabling consequence of many neurological diseases. Electrical stimulation of motor nerve endings has been reported to boost the effect of BoNT-A. To date, a wide
Alessandro Picelli +6 more
doaj +1 more source
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
Frontiers in Microbiology, 2022 Botulinum neurotoxin (BoNT) is one of the most dangerous bacterial toxins and a potential biological weapon component. BoNT mechanism of pathological action is based on inhibiting the release of neurotransmitters from nerve endings.
Artem A. Derkaev +9 more
doaj +1 more source
Treating the face of women with botulinum toxin type A: 7-year review [PDF]
Revista Brasileira de Cirurgia Plástica, 2023 Introduction: Botulinum toxin type A (BTX-A) is the number one aesthetic procedure worldwide, and the difficulty in standardizing the aesthetic treatment of the face results in a broad range of treatment possibilities.
Victor Hugo Lara Cardoso Sá +3 more
doaj +1 more source
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome [PDF]
International Neurourology Journal, 2015 Intravesical onabotulinumtoxinA (BoNT-A) injection is an effective treatment for overactive bladder syndrome (OAB) that is refractory to antimuscarinics.
Chun-Hou Liao, Hann-Chorng Kuo
doaj +1 more source
The binding of botulinum neurotoxins to different peripheral neurons [PDF]
, 2017 Botulinum neurotoxins are the most potent toxins known. The double receptor binding modality represents one of the most significant properties of botulinum neurotoxins and largely accounts for their incredible potency and lethality.
Rossetto, O.
core +1 more source
Brazilian Oral Research, 2018 Botulinum toxin type A is effective in reducing excessive gingival display caused by hyperfunctional upper lip elevator muscles; however, this effect is transient.
Taísa Figueiredo Chagas +5 more
doaj +1 more source
Applied Sciences, 2021 Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini +10 more
doaj +1 more source
Clinical Case Reports, 2020 The use of preoperative ventral botulinum toxin for giant hiatal hernia management.
Francisco Tustumi +8 more
doaj +1 more source